Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Immune Microenvironment”

112 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 112 results

Not applicableUnknownNCT06007989
What this trial is testing

Assessing the Relationship Between Hypoxia and the Immune Environment in Myeloma Patients (CHIME)

Who this might be right for
Myeloma
The Christie NHS Foundation Trust 10
Not applicableLooking for participantsNCT05038358
What this trial is testing

Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance Mechanisms

Who this might be right for
Primary TumorColon Tumor
University Hospital, Grenoble 60
Testing effectiveness (Phase 2)Study completedNCT01030900
What this trial is testing

Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas

Who this might be right for
Hodgkin LymphomaDiffuse Large B-Cell Lymphoma
National Cancer Institute (NCI) 50
Not applicableLooking for participantsNCT05644431
What this trial is testing

GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)

Who this might be right for
GastroEsophageal Cancer
Centre Leon Berard 50
Not applicableUnknownNCT05677724
What this trial is testing

Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment

Who this might be right for
HBVPrimary Liver Cancer
Fubing Wang 20
Early research (Phase 1)Ended earlyNCT03277209
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas

Who this might be right for
Pancreas Cancer
Weill Medical College of Cornell University 2
Not applicableLooking for participantsNCT06946745
What this trial is testing

Exploration of the Dynamic Changes and Mechanisms of the Immune Microenvironment in Advanced Colorectal Cancer Treated With IBI363 Combination Therapy

Who this might be right for
Immunotherapy
jianming xu 50
Not applicableNot Yet RecruitingNCT06827639
What this trial is testing

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

Who this might be right for
Head and Neck CancerUrologic CancerLung Cancer+2 more
Assistance Publique Hopitaux De Marseille 640
Not applicableUnknownNCT04749407
What this trial is testing

Biomarkers of Stage III Locally Advanced Unresectable Non-small-cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage III
First People's Hospital of Hangzhou 50
Testing effectiveness (Phase 2)WithdrawnNCT03532087
What this trial is testing

Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Borstkanker Onderzoek Groep
Early research (Phase 1)Active Not RecruitingNCT05081479
What this trial is testing

N-Acetylcysteine (N-AC) in People Receiving CAR T-cell Therapy for Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 9
Not applicableLooking for participantsNCT04904146
What this trial is testing

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

Who this might be right for
Mycosis FungoidesSezary Syndrome
Lund University Hospital 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05507112
What this trial is testing

TIME in Immunotherapy Combined With nCRT for Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)UnknownNCT05044728
What this trial is testing

Exploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy in Patients With Solid Tumors of the Chest.

Who this might be right for
Non-small Cell Lung CancerEsophageal Squamous Cell Carcinoma
Sichuan Cancer Hospital and Research Institute 80
Not applicableLooking for participantsNCT06581549
What this trial is testing

Immune Microenvironment and Gene Expression Profiling in Mesothelioma

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma; Lung
Istituto Oncologico Veneto IRCCS 220
Not applicableUnknownNCT04887545
What this trial is testing

Immune- and Microenvironment- Proteogenomics Profiling for Classifying Lung Cancer Patients

Who this might be right for
Lung CancerMalignancy
Universidade Nova de Lisboa 200
Not applicableStudy completedNCT03267641
What this trial is testing

Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Cancer Centre, Singapore 86
Testing effectiveness (Phase 2)Active Not RecruitingNCT04954339
What this trial is testing

DYNAmic Immune Microenvironment of HCC Treated With atezolIzumab Plus bevaCizumab

Who this might be right for
Hepatocellular Carcinoma
Tae Won Kim 40
Not applicableNot Yet RecruitingNCT04707365
What this trial is testing

Microenvironment and Immunity of Digestive Cancers - East Paris Multicentric Cohort

Who this might be right for
Colorectal CancerPancreas TumorBiliary Tract Tumor+1 more
Assistance Publique - Hôpitaux de Paris 200
Not applicableLooking for participantsNCT05304858
What this trial is testing

Tumor Microenvironment Analysis of Prostate Cancer Metastasis

Who this might be right for
Recurrent Prostate Cancer
Columbia University 16
Load More Results